$MYOK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MyoKardia, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MyoKardia, Inc.. Get notifications about new insider transactions in MyoKardia, Inc. for free.
Page: < prev 1 2 3 4 5 5 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 19 2020 | MYOK | MyoKardia, Inc. | Meeker David P | Director | Option Exercise | D | 47.77 | 6,600 | 315,282 | 0 | |
Nov 19 2020 | MYOK | MyoKardia, Inc. | Meeker David P | Director | Sell | U | 0.00 | 4,100 | 0 | 0 | 4.1 K to 0 (-100.00 %) |
Nov 19 2020 | MYOK | MyoKardia, Inc. | Meeker David P | Director | Option Exercise | D | 48.85 | 11,000 | 537,350 | 0 | |
Nov 19 2020 | MYOK | MyoKardia, Inc. | Meeker David P | Director | Option Exercise | D | 14.00 | 11,000 | 154,000 | 0 | |
Nov 19 2020 | MYOK | MyoKardia, Inc. | Meeker David P | Director | Option Exercise | D | 11.55 | 22,000 | 254,100 | 0 | |
Nov 19 2020 | MYOK | MyoKardia, Inc. | Meeker David P | Director | Sell | U | 0.00 | 4,100 | 0 | 0 | 4.1 K to 0 (-100.00 %) |
Jul 07 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 94.22 | 3,224 | 303,767 | 19,122 | 22.3 K to 19.1 K (-14.43 %) |
Jul 07 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 93.55 | 1,776 | 166,142 | 22,346 | 24.1 K to 22.3 K (-7.36 %) |
Jul 02 2020 | MYOK | MyoKardia, Inc. | Waynick Denelle J | General Counsel | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Jul 02 2020 | MYOK | MyoKardia, Inc. | Waynick Denelle J | General Counsel | Option Exercise | A | 93.84 | 80,000 | 7,507,200 | 80,000 | |
Jul 01 2020 | MYOK | MyoKardia, Inc. | CRANSTON MARY B | Director | Option Exercise | M | 11.69 | 21,629 | 252,843 | 0 | |
Jul 01 2020 | MYOK | MyoKardia, Inc. | CRANSTON MARY B | Director | Option Exercise | M | 11.69 | 371 | 4,337 | 21,629 | |
Jul 01 2020 | MYOK | MyoKardia, Inc. | CRANSTON MARY B | Director | Sell | S | 96.59 | 21,329 | 2,060,179 | 0 | 21.3 K to 0 (-100.00 %) |
Jul 01 2020 | MYOK | MyoKardia, Inc. | CRANSTON MARY B | Director | Sell | S | 97.25 | 300 | 29,176 | 21,329 | 21.6 K to 21.3 K (-1.39 %) |
Jul 01 2020 | MYOK | MyoKardia, Inc. | CRANSTON MARY B | Director | Buy | M | 11.69 | 21,629 | 252,843 | 21,629 | 0 to 21.6 K |
Jul 01 2020 | MYOK | MyoKardia, Inc. | CRANSTON MARY B | Director | Sell | S | 98.68 | 371 | 36,611 | 0 | 371 to 0 (-100.00 %) |
Jul 01 2020 | MYOK | MyoKardia, Inc. | CRANSTON MARY B | Director | Buy | M | 11.69 | 371 | 4,337 | 371 | 0 to 371 |
Jun 22 2020 | MYOK | MyoKardia, Inc. | PERRY MARK L | Director | Option Exercise | A | 0.00 | 1,800 | 0 | 1,800 | |
Jun 22 2020 | MYOK | MyoKardia, Inc. | PERRY MARK L | Director | Option Exercise | A | 100.27 | 3,000 | 300,810 | 3,000 | |
Jun 22 2020 | MYOK | MyoKardia, Inc. | CRANSTON MARY B | Director | Option Exercise | A | 0.00 | 1,800 | 0 | 1,800 | |
Jun 22 2020 | MYOK | MyoKardia, Inc. | CRANSTON MARY B | Director | Option Exercise | A | 100.27 | 3,000 | 300,810 | 3,000 | |
Jun 22 2020 | MYOK | MyoKardia, Inc. | AGARWAL SUNIL | Director | Option Exercise | A | 0.00 | 1,800 | 0 | 1,800 | |
Jun 22 2020 | MYOK | MyoKardia, Inc. | AGARWAL SUNIL | Director | Option Exercise | A | 100.27 | 3,000 | 300,810 | 3,000 | |
Jun 22 2020 | MYOK | MyoKardia, Inc. | Popovits Kimberly J | Director | Option Exercise | A | 0.00 | 1,800 | 0 | 1,800 | |
Jun 22 2020 | MYOK | MyoKardia, Inc. | Popovits Kimberly J | Director | Option Exercise | A | 100.27 | 3,000 | 300,810 | 3,000 | |
Jun 22 2020 | MYOK | MyoKardia, Inc. | Meeker David P | Director | Option Exercise | A | 0.00 | 1,800 | 0 | 1,800 | |
Jun 22 2020 | MYOK | MyoKardia, Inc. | Meeker David P | Director | Option Exercise | A | 100.27 | 3,000 | 300,810 | 3,000 | |
Jun 22 2020 | MYOK | MyoKardia, Inc. | YARNO WENDY L | Director | Option Exercise | A | 0.00 | 1,800 | 0 | 1,800 | |
Jun 22 2020 | MYOK | MyoKardia, Inc. | YARNO WENDY L | Director | Option Exercise | A | 100.27 | 3,000 | 300,810 | 3,000 | |
Jun 16 2020 | MYOK | MyoKardia, Inc. | AGARWAL SUNIL | Director | Option Exercise | M | 0.00 | 2,300 | 0 | 0 | |
Jun 16 2020 | MYOK | MyoKardia, Inc. | AGARWAL SUNIL | Director | Buy | M | 0.00 | 2,300 | 0 | 2,300 | 0 to 2.3 K |
Jun 16 2020 | MYOK | MyoKardia, Inc. | Popovits Kimberly J | Director | Option Exercise | M | 0.00 | 2,300 | 0 | 0 | |
Jun 16 2020 | MYOK | MyoKardia, Inc. | Popovits Kimberly J | Director | Buy | M | 0.00 | 2,300 | 0 | 2,300 | 0 to 2.3 K |
Jun 16 2020 | MYOK | MyoKardia, Inc. | Meeker David P | Director | Option Exercise | M | 0.00 | 2,300 | 0 | 0 | |
Jun 16 2020 | MYOK | MyoKardia, Inc. | Meeker David P | Director | Buy | M | 0.00 | 2,300 | 0 | 2,300 | 0 to 2.3 K |
Jun 16 2020 | MYOK | MyoKardia, Inc. | PERRY MARK L | Director | Option Exercise | M | 0.00 | 2,300 | 0 | 0 | |
Jun 16 2020 | MYOK | MyoKardia, Inc. | PERRY MARK L | Director | Buy | M | 0.00 | 2,300 | 0 | 27,708 | 25.4 K to 27.7 K (+9.05 %) |
Jun 16 2020 | MYOK | MyoKardia, Inc. | YARNO WENDY L | Director | Option Exercise | M | 0.00 | 2,300 | 0 | 0 | |
Jun 16 2020 | MYOK | MyoKardia, Inc. | YARNO WENDY L | Director | Buy | M | 0.00 | 2,300 | 0 | 3,708 | 1.4 K to 3.7 K (+163.35 %) |
Jun 16 2020 | MYOK | MyoKardia, Inc. | CRANSTON MARY B | Director | Option Exercise | M | 0.00 | 2,300 | 0 | 0 | |
Jun 16 2020 | MYOK | MyoKardia, Inc. | CRANSTON MARY B | Director | Buy | M | 0.00 | 2,300 | 0 | 2,300 | 0 to 2.3 K |
Jun 04 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 104.65 | 319 | 33,382 | 24,122 | 24.4 K to 24.1 K (-1.31 %) |
Jun 04 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 103.77 | 1,885 | 195,609 | 24,441 | 26.3 K to 24.4 K (-7.16 %) |
Jun 04 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 102.78 | 1,396 | 143,481 | 26,326 | 27.7 K to 26.3 K (-5.04 %) |
Jun 04 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 101.72 | 800 | 81,378 | 27,722 | 28.5 K to 27.7 K (-2.80 %) |
Jun 04 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 100.60 | 600 | 60,357 | 28,522 | 29.1 K to 28.5 K (-2.06 %) |
Jun 04 2020 | MYOK | MyoKardia, Inc. | Bauer Jake | Chief Business Offi ... | Grant | A | 50.41 | 293 | 14,771 | 57,784 | 57.5 K to 57.8 K (+0.51 %) |
May 20 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 125.00 | 10,000 | 1,250,000 | 29,122 | 39.1 K to 29.1 K (-25.56 %) |
May 13 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 103.33 | 600 | 61,998 | 39,122 | 39.7 K to 39.1 K (-1.51 %) |
May 13 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 102.56 | 3,519 | 360,921 | 39,722 | 43.2 K to 39.7 K (-8.14 %) |
May 13 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 101.90 | 18,581 | 1,893,486 | 43,241 | 61.8 K to 43.2 K (-30.06 %) |
May 13 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 100.51 | 1,700 | 170,860 | 61,822 | 63.5 K to 61.8 K (-2.68 %) |
May 13 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 98.69 | 600 | 59,213 | 63,522 | 64.1 K to 63.5 K (-0.94 %) |
May 06 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 60.15 | 305 | 18,346 | 74,122 | 74.4 K to 74.1 K (-0.41 %) |
May 06 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 59.10 | 2,909 | 171,916 | 74,427 | 77.3 K to 74.4 K (-3.76 %) |
May 06 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 58.05 | 400 | 23,218 | 77,336 | 77.7 K to 77.3 K (-0.51 %) |
May 06 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 56.93 | 1,386 | 78,907 | 77,736 | 79.1 K to 77.7 K (-1.75 %) |
May 04 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 11,500 | 17,328 | 121,626 | |
May 04 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 11,500 | 17,328 | 289,582 | 278.1 K to 289.6 K (+4.14 %) |
May 04 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Grant | A | 50.41 | 421 | 21,224 | 278,082 | 277.7 K to 278.1 K (+0.15 %) |
Apr 20 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Gift | G | 0.00 | 122,661 | 0 | 0 | 122.7 K to 0 (-100.00 %) |
Apr 20 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Gift | G | 0.00 | 200,865 | 0 | 277,661 | 76.8 K to 277.7 K (+261.56 %) |
Apr 20 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Gift | G | 0.00 | 200,865 | 0 | 122,661 | 323.5 K to 122.7 K (-62.09 %) |
Apr 20 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 55.00 | 1,000 | 55,000 | 76,796 | 77.8 K to 76.8 K (-1.29 %) |
Apr 10 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 50.00 | 1,500 | 75,000 | 77,796 | 79.3 K to 77.8 K (-1.89 %) |
Apr 10 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 50.00 | 1,500 | 75,000 | 77,796 | 79.3 K to 77.8 K (-1.89 %) |
Apr 07 2020 | MYOK | MyoKardia, Inc. | Harris Taylor C. | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,750 | 0 | 7,500 | |
Apr 07 2020 | MYOK | MyoKardia, Inc. | Harris Taylor C. | Chief Financial Off ... | Sell | S | 46.99 | 1,305 | 61,322 | 7,438 | 8.7 K to 7.4 K (-14.93 %) |
Apr 07 2020 | MYOK | MyoKardia, Inc. | Harris Taylor C. | Chief Financial Off ... | Buy | M | 0.00 | 3,750 | 0 | 8,743 | 5 K to 8.7 K (+75.11 %) |
Apr 06 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 46.23 | 600 | 27,736 | 79,296 | 79.9 K to 79.3 K (-0.75 %) |
Apr 06 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 45.35 | 300 | 13,605 | 79,896 | 80.2 K to 79.9 K (-0.37 %) |
Apr 06 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 44.47 | 1,000 | 44,469 | 80,196 | 81.2 K to 80.2 K (-1.23 %) |
Apr 06 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 43.51 | 600 | 26,107 | 81,196 | 81.8 K to 81.2 K (-0.73 %) |
Mar 04 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 65.97 | 22 | 1,451 | 81,796 | 81.8 K to 81.8 K (-0.03 %) |
Mar 04 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 65.19 | 1,800 | 117,346 | 81,818 | 83.6 K to 81.8 K (-2.15 %) |
Mar 04 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 64.35 | 2,070 | 133,203 | 83,618 | 85.7 K to 83.6 K (-2.42 %) |
Mar 04 2020 | MYOK | MyoKardia, Inc. | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 63.40 | 1,108 | 70,246 | 85,688 | 86.8 K to 85.7 K (-1.28 %) |
Feb 19 2020 | MYOK | MyoKardia Inc | LADD CYNTHIA J | General Counsel | Option Exercise | A | 0.00 | 10,034 | 0 | 10,034 | |
Feb 19 2020 | MYOK | MyoKardia Inc | LADD CYNTHIA J | General Counsel | Option Exercise | A | 70.40 | 31,079 | 2,187,962 | 31,079 | |
Feb 19 2020 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | A | 0.00 | 46,083 | 0 | 46,083 | |
Feb 19 2020 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | A | 70.40 | 142,733 | 10,048,403 | 142,733 | |
Feb 19 2020 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Option Exercise | A | 0.00 | 14,591 | 0 | 14,591 | |
Feb 19 2020 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Option Exercise | A | 70.40 | 45,193 | 3,181,587 | 45,193 | |
Feb 19 2020 | MYOK | MyoKardia Inc | McDowell Robert Scott | Chief Scientific Of ... | Option Exercise | A | 0.00 | 12,533 | 0 | 12,533 | |
Feb 19 2020 | MYOK | MyoKardia Inc | McDowell Robert Scott | Chief Scientific Of ... | Option Exercise | A | 70.40 | 38,818 | 2,732,787 | 38,818 | |
Feb 19 2020 | MYOK | MyoKardia Inc | Fairey William | See Remarks | Option Exercise | A | 0.00 | 12,598 | 0 | 12,598 | |
Feb 19 2020 | MYOK | MyoKardia Inc | Fairey William | See Remarks | Option Exercise | A | 70.40 | 39,022 | 2,747,149 | 39,022 | |
Feb 19 2020 | MYOK | MyoKardia Inc | Harris Taylor C. | Chief Financial Off ... | Option Exercise | A | 0.00 | 14,871 | 0 | 14,871 | |
Feb 19 2020 | MYOK | MyoKardia Inc | Harris Taylor C. | Chief Financial Off ... | Option Exercise | A | 70.40 | 46,060 | 3,242,624 | 46,060 | |
Feb 05 2020 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 69.74 | 1,000 | 69,744 | 86,777 | 87.8 K to 86.8 K (-1.14 %) |
Feb 05 2020 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 69.27 | 4,000 | 277,077 | 87,777 | 91.8 K to 87.8 K (-4.36 %) |
Feb 03 2020 | MYOK | MyoKardia Inc | Fairey William | See Remarks | Option Exercise | M | 0.00 | 8,125 | 0 | 24,375 | |
Feb 03 2020 | MYOK | MyoKardia Inc | Fairey William | See Remarks | Sell | S | 68.04 | 2,899 | 197,248 | 5,226 | 8.1 K to 5.2 K (-35.68 %) |
Feb 03 2020 | MYOK | MyoKardia Inc | Fairey William | See Remarks | Buy | M | 0.00 | 8,125 | 0 | 8,125 | 0 to 8.1 K |
Jan 14 2020 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 75.39 | 5,000 | 376,965 | 91,777 | 96.8 K to 91.8 K (-5.17 %) |
Jan 14 2020 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 75.39 | 5,000 | 376,965 | 91,777 | 96.8 K to 91.8 K (-5.17 %) |
Jan 07 2020 | MYOK | MyoKardia Inc | Harris Taylor C. | Chief Financial Off ... | Sell | S | 68.45 | 1,683 | 115,203 | 4,993 | 6.7 K to 5 K (-25.21 %) |
Jan 07 2020 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 68.45 | 12,687 | 868,439 | 96,777 | 109.5 K to 96.8 K (-11.59 %) |
Jan 07 2020 | MYOK | MyoKardia Inc | McDowell Robert Scott | Chief Scientific Of ... | Sell | S | 68.45 | 2,650 | 181,395 | 5,383 | 8 K to 5.4 K (-32.99 %) |
Jan 07 2020 | MYOK | MyoKardia Inc | LADD CYNTHIA J | General Counsel | Sell | S | 68.45 | 1,849 | 126,566 | 2,851 | 4.7 K to 2.9 K (-39.34 %) |
Jan 07 2020 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Option Exercise | M | 1.51 | 10,000 | 15,100 | 6,326 | |
Jan 07 2020 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Sell | S | 68.45 | 2,466 | 168,800 | 57,491 | 60 K to 57.5 K (-4.11 %) |
Jan 07 2020 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Buy | M | 1.51 | 10,000 | 15,100 | 59,957 | 50 K to 60 K (+20.02 %) |
Jan 03 2020 | MYOK | MyoKardia Inc | McDowell Robert Scott | Chief Scientific Of ... | Option Exercise | M | 0.00 | 4,950 | 0 | 14,850 | |
Jan 03 2020 | MYOK | MyoKardia Inc | McDowell Robert Scott | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,925 | 0 | 3,850 | |
Jan 03 2020 | MYOK | MyoKardia Inc | McDowell Robert Scott | Chief Scientific Of ... | Buy | M | 0.00 | 6,875 | 0 | 8,033 | 1.2 K to 8 K (+593.70 %) |
Jan 03 2020 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 0.00 | 20,300 | 0 | 60,900 | |
Jan 03 2020 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 0.00 | 7,650 | 0 | 15,300 | |
Jan 03 2020 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 72.27 | 2,084 | 150,617 | 109,464 | 111.5 K to 109.5 K (-1.87 %) |
Jan 03 2020 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 71.59 | 2,616 | 187,287 | 111,548 | 114.2 K to 111.5 K (-2.29 %) |
Jan 03 2020 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 70.35 | 300 | 21,105 | 114,164 | 114.5 K to 114.2 K (-0.26 %) |
Jan 03 2020 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 0.00 | 27,950 | 0 | 114,464 | 86.5 K to 114.5 K (+32.31 %) |
Jan 03 2020 | MYOK | MyoKardia Inc | LADD CYNTHIA J | General Counsel | Option Exercise | M | 0.00 | 4,700 | 0 | 14,100 | |
Jan 03 2020 | MYOK | MyoKardia Inc | LADD CYNTHIA J | General Counsel | Buy | M | 0.00 | 4,700 | 0 | 4,700 | 0 to 4.7 K |
Jan 03 2020 | MYOK | MyoKardia Inc | Harris Taylor C. | Chief Financial Off ... | Option Exercise | M | 0.00 | 4,250 | 0 | 12,750 | |
Jan 03 2020 | MYOK | MyoKardia Inc | Harris Taylor C. | Chief Financial Off ... | Buy | M | 0.00 | 4,250 | 0 | 6,676 | 2.4 K to 6.7 K (+175.19 %) |
Jan 03 2020 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Option Exercise | M | 0.00 | 4,950 | 0 | 14,850 | |
Jan 03 2020 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Option Exercise | M | 0.00 | 1,425 | 0 | 2,850 | |
Jan 03 2020 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Buy | M | 0.00 | 6,375 | 0 | 49,957 | 43.6 K to 50 K (+14.63 %) |
Dec 23 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Option Exercise | M | 13.90 | 7,500 | 104,250 | 0 | |
Dec 23 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Option Exercise | M | 9.08 | 10,000 | 90,800 | 8,748 | |
Dec 23 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Sell | S | 70.07 | 18,916 | 1,325,421 | 43,582 | 62.5 K to 43.6 K (-30.27 %) |
Dec 23 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Buy | M | 13.90 | 7,500 | 104,250 | 62,498 | 55 K to 62.5 K (+13.64 %) |
Dec 23 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Buy | M | 9.08 | 10,000 | 90,800 | 54,998 | 45 K to 55 K (+22.22 %) |
Dec 23 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Option Exercise | M | 13.90 | 7,500 | 104,250 | 0 | |
Dec 23 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Option Exercise | M | 9.08 | 10,000 | 90,800 | 8,748 | |
Dec 23 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Sell | S | 70.07 | 18,916 | 1,325,421 | 43,582 | 62.5 K to 43.6 K (-30.27 %) |
Dec 23 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Buy | M | 13.90 | 7,500 | 104,250 | 62,498 | 55 K to 62.5 K (+13.64 %) |
Dec 23 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Buy | M | 9.08 | 10,000 | 90,800 | 54,998 | 45 K to 55 K (+22.22 %) |
Dec 04 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 65.14 | 4,350 | 283,342 | 86,514 | 90.9 K to 86.5 K (-4.79 %) |
Dec 04 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 64.24 | 650 | 41,755 | 90,864 | 91.5 K to 90.9 K (-0.71 %) |
Dec 02 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Sell | S | 66.32 | 800 | 53,056 | 44,998 | 45.8 K to 45 K (-1.75 %) |
Dec 02 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Sell | S | 65.52 | 7,336 | 480,655 | 45,798 | 53.1 K to 45.8 K (-13.81 %) |
Dec 02 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Sell | S | 65.13 | 13,096 | 852,977 | 53,134 | 66.2 K to 53.1 K (-19.77 %) |
Nov 08 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Grant | A | 40.07 | 162 | 6,491 | 66,230 | 66.1 K to 66.2 K (+0.25 %) |
Nov 06 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 59.07 | 5,000 | 295,365 | 91,514 | 96.5 K to 91.5 K (-5.18 %) |
Nov 06 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Grant | A | 40.07 | 44 | 1,763 | 96,514 | 96.5 K to 96.5 K (+0.05 %) |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Option Exercise | M | 11.95 | 3,000 | 35,850 | 3,250 | |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Option Exercise | M | 11.95 | 364 | 4,350 | 100,613 | |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Option Exercise | M | 11.95 | 364 | 4,350 | 100,977 | |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Option Exercise | M | 11.95 | 2,500 | 29,875 | 101,341 | |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Option Exercise | M | 11.95 | 364 | 4,350 | 103,841 | |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Option Exercise | M | 11.95 | 364 | 4,350 | 104,205 | |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Option Exercise | M | 11.95 | 363 | 4,338 | 104,569 | |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Option Exercise | M | 11.95 | 364 | 4,350 | 104,932 | |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Option Exercise | M | 11.95 | 364 | 4,350 | 105,296 | |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Option Exercise | M | 11.95 | 4,500 | 53,775 | 105,660 | |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Option Exercise | M | 11.95 | 5,457 | 65,211 | 110,160 | |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Buy | M | 11.95 | 3,000 | 35,850 | 22,157 | 19.2 K to 22.2 K (+15.66 %) |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Buy | M | 11.95 | 364 | 4,350 | 19,157 | 18.8 K to 19.2 K (+1.94 %) |